- Home
- FCN vs BRKR Comparison
FCN vs BRKR Comparison
Compare FCN & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FCN | BRKR |
|---|---|---|
| Founded | 1982 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.6B |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FCN | BRKR |
|---|---|---|
| Price | $177.05 | $37.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 13 |
| Target Price | ★ $165.00 | $48.92 |
| AVG Volume (30 Days) | 357.3K | ★ 1.9M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | ★ 5.51 | N/A |
| EPS | ★ 8.24 | N/A |
| Revenue | ★ $3,788,857,000.00 | $1,895,600,000.00 |
| Revenue This Year | $7.39 | $6.27 |
| Revenue Next Year | $7.10 | $3.78 |
| P/E Ratio | $22.01 | ★ N/A |
| Revenue Growth | ★ 2.44 | N/A |
| 52 Week Low | $149.31 | $28.53 |
| 52 Week High | $186.70 | $56.22 |
Technical Indicators
Market Signals| Indicator | FCN | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 54.37 |
| Support Level | $161.24 | $35.88 |
| Resistance Level | $179.96 | $41.29 |
| Average True Range (ATR) | 5.07 | 1.64 |
| MACD | 0.64 | 0.60 |
| Stochastic Oscillator | 59.48 | 67.66 |
Price Performance
Historical ComparisonAbout FCN FTI Consulting Inc.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.